Morgan Stanley upgraded Barry Callebaut to overweight while downgrading Lindt to underweight, citing diverging impacts from falling cocoa prices on the Swiss chocolate makers. The firm raised Barry Callebaut's price target to SFr1,600 from SFr1,270, while cutting Lindt's target to SFr108,500 from SFr125,500, implying a roughly 25% potential relative return between the stocks.

Cocoa prices have plummeted approximately 40% year-to-date and 75% from 2024 peaks, driven by expectations of a surplus in the 2025/26 harvest season. Barry Callebaut trades at 23x 2026 estimated price-to-earnings with a 26% three-year EPS compound annual growth rate, while Lindt trades at 39x 2026 P/E for an 8% three-year EPS CAGR. Morgan Stanley raised its net EPS and FCF estimates for Barry Callebaut by 3% and 4% respectively through 2029.

The divergence reflects different business models: Barry Callebaut benefits from forward selling and lower input costs, while Lindt faces greater price rollback risks in Europe where chocolate prices rose 34% over two years. Private label penetration stands at 19% in Europe versus 3% in the U.S., creating additional pressure on branded manufacturers. The firm's DCF valuations place Barry Callebaut at CHF1,580 and Lindt at CHF119,365, reflecting their contrasting outlooks in the current market environment.